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Cationic Europium Complexes for Visualizing Fluctuations in
Mitochondrial ATP Levels in Living Cells
Romain Mailhot,[a] Thomas Traviss-Pollard,[a] Robert Pal,[b] and Stephen J. Butler*[a]
Abstract: The ability to study cellular metabolism and enzy-
matic processes involving adenosine triphosphate (ATP) is
impeded by the lack of imaging probes capable of signalling
the concentration and distribution of intracellular ATP rapid-
ly, with high sensitivity. We report here the first example of a
luminescent lanthanide complex capable of visualizing
changes in the concentration of ATP in the mitochondria of
living cells. Four cationic europium(III) complexes [Eu.1–4]+
have been synthesized and their binding capabilities to-
wards nucleoside polyphosphate anions examined in aque-
ous solution at physiological pH. Complexes [Eu.1]+ and
[Eu.3]+ bearing hydrogen bond donor groups in the pend-
ant arms showed excellent discrimination between ATP, ADP
and monophosphate species. Complex [Eu.3]+ showed rela-
tively strong binding to ATP (logKa=5.8), providing a rapid,
long-lived luminescent signal that enabled its detection in a
highly competitive aqueous medium containing biologically
relevant concentrations of Mg2+ , ADP, GTP, UTP and human
serum albumin. This EuIII complex responds linearly to ATP
within the physiological concentration range (1–5 mm), and
was used to continuously monitor the apyrase-catalyzed hy-
drolysis of ATP to ADP in vitro. We demonstrate that [Eu.3]+
can permeate mammalian (NIH-3T3) cells efficiently and lo-
calize to the mitochondria selectively, permitting real-time
visualization of elevated mitochondrial ATP levels following
treatment with a broad spectrum kinase inhibitor, stauro-
sporine, as well as depleted ATP levels upon treatment with
potassium cyanide under glucose starvation conditions.
Introduction
Adenosine triphosphate (ATP) is the most abundant nucleoside
polyphosphate (NPP) anion in cells[1,2] and serves as the chemi-
cal energy source for most biological processes, including or-
ganelle transport, muscle contraction and maintenance of neu-
ronal membrane potential.[2–4] Despite its importance, there are
surprisingly few imaging probes capable of signalling the pres-
ence of ATP rapidly, reversibly and selectively under physiologi-
cal conditions.[5, 6] We have addressed this challenge by creat-
ing a luminescent europium(III) complex capable of imaging
dynamic changes in the concentration of ATP in the mitochon-
dria of living cells. The majority of ATP is generated by the mi-
tochondria by oxidative phosphorylation. Numerous enzymes
utilize ATP as a substrate, including ATPases, kinases, and RNA
polymerases; thus ATP plays a key role in signalling and the
regulation of enzyme function.[1, 2, 6] The release of ATP to the
extracellular space has been identified in both damaged and
apoptotic cells.2 Extracellular ATP also serves as a signalling
molecule by binding to purinergic receptors,3 thereby media-
ting an immunological or nervous response. The concentration
of ATP varies considerably, from nanomolar extracellular con-
centrations to millimolar concentrations in the cytosol and cer-
tain organelles (e.g. mitochondria).[1, 2] To gain a better under-
standing of the wide range of dynamic processes involving
ATP, non-invasive imaging probes are required that can signal
changes in ATP levels by modulation of luminescence, thereby
providing spatial and temporal information rapidly, with high
sensitivity.[5a,6a]
Current methods for monitoring the concentration of ATP in
living cells have limitations.[2, 5a] The enzyme firefly luciferase
can be expressed in cells to measure ATP levels indirectly, by
catalyzing a chemiluminescent reaction between ATP and luci-
ferin.[7] However, this method consumes ATP, which may per-
turb the cellular energy status, preventing accurate quantifica-
tion of ATP.[8, 9] Genetically encoded fluorescent biosensors (e.g.
ATeam,[6a] PercevalHR)[6b] have been developed to measure ATP
successfully within specific cellular compartments. However,
biosensors encoded within cells can require time consuming
protein expression and maturation procedures and are intrinsi-
cally pH sensitive;[6b] small changes in intracellular pH (<0.1
units) have been shown to generate bias in the emission re-
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sponse, which can complicate interpretation of the observed
signal.[9]
An attractive alternative strategy involves the creation of dis-
crete ATP-responsive synthetic receptors that exhibit intrinsic
cellular uptake and localization behaviour.[1, 5a] The majority of
synthetic receptors for ATP comprise a fluorescent organic indi-
cator linked to a positively charged recognition group, such as
imidazolium or guanidinium units, or coordinated zinc(II) ions,
which form strong electrostatic or metal-ligand interactions
with the triphosphate fragment of ATP.[10] Only a few ATP-selec-
tive probes have been successfully applied to imaging ATP in
living cells.[5a–d] Each of these probes emits a short-lived fluo-
rescence signal, typically at wavelengths between 375 and
540 nm. Consequently, their signal overlaps with background
autofluorescence arising from endogenous molecules, which
can complicate intensity-based measurements.[11] In two cases,
the detection range of the receptor is very low (0.1–10 mm),[5a,b]
and the fluorescence response is saturated at ATP concentra-
tions below those expected in cells (1–5 mm).[12] Chang and
co-workers developed a probe capable of detecting ATP within
the 2–10 mm range, in a viscous medium of glycerol/water
(60:40).[5c] However, this probe is unable to respond to ATP in
100% aqueous solution at physiological pH, hence its utility in
live-cell imaging is limited and dependent on variations in vis-
cosity within the cell.
Importantly, during in vitro testing, anion affinity and selec-
tivity is rarely assessed in a competitive ionic medium that re-
sembles intracellular fluid.[5c] This is critical, because it defines
the target concentration range and the nature and abundance
of potentially interfering species, including other phosphoan-
ions (e.g. ADP, AMP, GTP, HPO4
2@), cations that bind strongly to
ATP (e.g. Mg2+ and Ca2+ ions), and proteins, which
can interact with the probe causing either quenching
or enhancement of emission. The influence of such a
competitive ionic environment on the probe’s anion
affinity and selectivity should be studied, to optimize
its practical utility in live-cell imaging experiments.[13]
In recent years, stable luminescent europium(III)
and terbium(III) complexes have emerged as attrac-
tive tools for use in cellular imaging.[14] Notably, a
series of the brightest EuIII complexes have been de-
veloped as efficient cellular stains, designed to local-
ize preferentially in specific organelles.[15,16] Stable
EuIII and TbIII complexes offer significant advantages
over conventional fluorescent organic dyes, including
a large separation between the absorption and emis-
sion bands, long emission lifetimes[17] (within the mil-
lisecond range) that enable complete removal of
background autofluorescence by using time-resolved
imaging techniques, and well-defined emission
bands that permit ratiometric analysis.[18] Certain EuIII
and TbIII complexes have been shown to bind rever-
sibly to anions in aqueous media, including bicar-
bonate,[19] fluoride,[20] lactate,
[21] phosphate[22] and
phosphorylated peptides.[23] Anion binding can be
signalled by changes in the intensity ratio of two LnIII
emission bands or by changes in emission lifetime of
the complex.[13,24] However, examples of LnIII complexes that
bind to NPP anions such as ATP are rare.[25–28] Binding to ATP is
usually weak and causes quenching of luminescence due to
energy transfer to the nucleotide base[25,27] or displacement of
a coordinated sensitizing ligand from the LnIII ion (decomplexa-
tion).[28,29] Probes that utilise quenching of luminescence are
less desirable for use in cellular imaging as other competitive
quenching processes may generate the observed decrease in
emission intensity.[14b]
In this work, we report a series of luminescent cationic EuIII
complexes [Eu.1–4]+ that bind reversibly and with differential
affinities to NPP anions in aqueous solution at physiological
pH (Figure 1). Each EuIII complex is based on a C2-symmetric
octadentate ligand bearing two coordinating quinoline groups
that sensitize EuIII luminescence. Addition of ATP to complexes
[Eu.1]+ and [Eu.3]+ results in rapid displacement of the coordi-
nated water molecule, giving rise to dramatic enhancements
in EuIII luminescence. Complex [Eu.3]+ is very effective at bind-
ing to ATP in water at physiological pH, by means of a strong
metal-ligand interaction, possibly strengthened by hydrogen
bonds to the quinoline amide arms. [Eu.3]+ can discriminate
effectively between ATP and ADP in the presence of high con-
centrations of Mg2+ ions, permitting real-time analysis of the
enzymatic hydrolysis of ATP to ADP in vitro. We demonstrate
that [Eu.3]+ can signal changes in the ratio of ATP/ADP in a si-
mulated intracellular fluid containing biorelevant concentra-
tions of several NPP anions including GTP and UTP, as well as
Mg2+ ions and protein. [Eu.3]+ was shown to permeate NIH-
3T3 cells efficiently and localize selectively to the mitochondria,
providing a strong luminescent signal that can report on dy-
namic changes in mitochondrial ATP levels within living cells.
Figure 1. (A) Signalling mechanism and proposed binding mode between [Eu.3]+ and
ATP; (B) Structures of cationic EuIII complexes [Eu.1–4]+ .
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This new class of EuIII complexes offers a number of improve-
ments in performance compared to existing probes for ATP,
including a long-lived luminescence signal that is sensitive to
ATP levels within the physiological range (1–5 mm), with mini-
mal interference from biomolecule autofluorescence or
changes in cellular pH. In addition, [Eu.3]+ possesses a distinc-
tive subcellular localization profile that allows ATP levels to be
monitored within a specific region of the cell.
Results and Discussion
Complex design and synthesis
Each EuIII complex contains two coordinating quinoline groups
that act as efficient sensitizers of EuIII emission.[30] Complexes
[Eu.1]+ and [Eu.2]+ were synthesised previously[20a] and pos-
sess two negatively charged carboxylate groups that coordi-
nate to the EuIII ion, whereas complexes [Eu.3]+ and [Eu.4]+
possess two neutral carbonyl amide donor groups, functional-
ized with terminal carboxylate moieties to increase water solu-
bility. The carbonyl amide groups in [Eu.3]+ and [Eu.4]+ were
expected to increase the electropositive nature of the EuIII
metal compared to [Eu.1]+ and [Eu.2]+ , thus strengthening
the electrostatic interaction between the EuIII ion and negative-
ly charged NPP anions in aqueous solution. Additionally, it was
envisaged that the increased local positive charge of [Eu.3]+
and [Eu.4]+ , together with the amphipathic nature of the sur-
rounding ligands, would facilitate cellular uptake of the EuIII
complexes, and potentially promote selective localization to
the negatively charged inner membrane of the mitochon-
dria.16, 5a
Complexes [Eu.1]+ and [Eu.3]+ possess hydrogen-bond
donor (amide) groups at the 7-position of the coordinated
quinoline chromophores. We envisaged that NPP anions such
as ATP would coordinate to the EuIII ion via the terminal phos-
phate group, enabling the adjacent phosphate group to
engage in hydrogen bonding interactions with quinoline
amide N-H groups (Figure 1B), thereby enhancing selectivity
over monophosphate species. Indeed, we have shown recently
that the cooperative use of metal-ligand interactions in combi-
nation with hydrogen bonding can provide excellent selectivity
for nucleoside polyphosphate anions over monophosphate
anions (e.g. AMP, cAMP, HPO4
2@, phosphorylated amino acids),
where no such hydrogen-bonding interactions can occur.[31,32]
To investigate the function of the hydrogen bond-donor
groups in the ATP recognition process, we prepared two con-
trol complexes, [Eu.2]+ and [Eu.4]+ , which lack quinoline
amide groups.
Details of the synthesis and characterization of complexes
[Eu.3]+ and [Eu.4]+ are provided in the supporting informa-
tion (Figure S1–S3 for synthetic schemes). Briefly, a cyclen de-
rivative bearing two trans-related secondary amines was react-
ed with an appropriately functionalized 2-methylquinoline me-
sylate ester or 2-(chloromethyl)quinoline in the presence of
K2CO3, to give the protected macrocyclic ligand. The terminal
ethyl ester protecting groups of the two carbonyl amide arms
were hydrolyzed using 0.5m NaOH solution. Subsequent addi-
tion of one equivalent of EuCl3 in a mixture of water/methanol
at pH 7–8 gave the water soluble EuIII complexes [Eu.3]+ and
[Eu.4]+ , after purification by preparative reverse-phase HPLC.
Table 1 shows selected photophysical data for [Eu.1–4]+ .
The UV/Vis absorption spectra of [Eu.1]+ and [Eu.3]+ are simi-
lar and comprise of a broad band centred at 332 nm and
330 nm, respectively, tailing out to 370 nm, whereas [Eu.2]+
and [Eu.4]+ each feature two narrow bands with maxima at
303 and 318 nm (Figure S4-S7). The emission spectrum of each
complex in aqueous buffer (10 mm HEPES, pH 7.4) was well
separated from the absorption spectrum, as illustrated by
[Eu.3]+ in Figure 2. The emission spectra of [Eu.1]+ , [Eu.2]+
and [Eu.4]+ showed similarities, displaying at least three com-
ponents in the DJ=1 (585–605 nm) band, and two distinguish-
able components within the DJ=2 (605–630 nm) band, consis-
tent with each complex adopting a structure of low symmetry
in water (Figure S8). For [Eu.3]+ , a rather different emission
spectrum was obtained, characterised by a pronounced DJ=2
band around 605–630 nm and two discernable components
within the DJ=4 band around 675–705 nm in the red region
of the visible spectrum (Figure 2). Emission quantum yields
were in the range 7–23% and emission lifetimes in H2O were
measured to be approximately 0.5 ms, and at least 50% larger
in D2O. The number of coordinated water molecules, q, was
determined to be one for each EuIII complex.[33] These data
suggested that complexes [Eu.1]+ and [Eu.3]+ were most
suited for use in live-cell imaging experiments, due to their
water solubility, long-lived luminescence and sufficiently long
excitation wavelengths of over 350 nm, thereby matching the
optics of standard fluorescence microscopes.
Table 1. Selected photophysical data for complexes [Eu.1–4]+ , measured
in 10 mm HEPES, pH 7.0, 25 8C.
Complex lmax [nm] e [m
@1 cm@1] fem [%]
[a] t(H2O) [ms] t(D2O) [ms] q
[b]
[Eu.1]+ 332 0.00125 7.0 0.49 1.38 1.2
[Eu.2]+ 318 0.00118 23 0.51 1.37 1.1
[Eu.3]+ 330 0.00077 6.5 0.56 1.22 0.8
[Eu.4]+ 318 0.00210 18 0.60 1.29 0.7
[a] Errors in quantum yields and lifetimes are :20%; [b] Values of hydra-
tion state, q (:20%) were derived using literature methods.[33]
Figure 2. Absorption (blue) and emission (red) spectra of [Eu.3]+ , recorded
in buffered aqueous solution (10 mm HEPES) at pH 7.0. lexc=330 nm, 25 8C.
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Anion binding studies at physiological pH
The EuIII emission spectra of [Eu.1–4]+ were recorded in pH 7.0
(10 mm HEPES) in the presence of a range of anions (1 mm)
(Figure S9–S12). Addition of 1 mm ATP to [Eu.1]+ or [Eu.3]+ re-
sulted in an immediate 10-fold enhancement in EuIII emission
intensity of the hypersensitive DJ=2 band (605–630 nm),
whereas adding ADP induced a 14-fold increase in emission in-
tensity (Figure S9 and S10). AMP and HPO4
2@ induced a much
smaller (approximately 2-fold) increase in emission intensity
while other monophosphate anions including cyclic AMP and
phosphorylated amino acids (pSer, pThr, pTyr) induced negligi-
ble spectral responses, as did chloride, sulphate, lactate, ace-
tate, glutathione, Na+ , K+ , Zn2+ , Mg2+ and Ca2+ ions. The gua-
nosine phosphate anions, GTP, GDP and GMP induced similar
spectral responses to those observed for ATP, ADP and AMP re-
spectively. The only other anions tested that induced a signifi-
cant spectral response were citrate and bicarbonate, which
caused a maximum 4-fold and 5-fold increase in the DJ=2
emission band, respectively. Control complexes [Eu.2]+ and
[Eu.4]+ , which lacked quinoline amide groups, showed a much
lower level of discrimination between NPP anions: a maximum
3-fold enhancement in intensity of the DJ=2 emission band
was observed in the presence of 1 mm ATP, ADP and AMP (Fig-
ure S11 and S12). Analysis of the relative change in total emis-
sion intensity (570–720 nm) resulted in a very similar anion se-
lectivity profile for each EuIII complex (Figure S13–S16).
The emission intensity of [Eu.3]+ was found to be particular-
ly sensitive to ATP concentration. Figure 3 shows the increase
in emission spectra of [Eu.3]+ in the presence of increasing
ATP levels (0–180 mm), revealing a dramatic 17-fold enhance-
ment in intensity at 614 nm within the DJ=2 band. Notably,
the emission spectral shape of [Eu.3]+ did not change signifi-
cantly, suggesting that only minor changes in conformation of
[Eu.3]+ occur upon binding to ATP. Emission lifetimes of
[Eu.3]+ measured in H2O and D2O in the absence and presence
of ATP were consistent with a hydration state, q, of 0.8(:20%)
and zero, respectively (Table S1), establishing that ATP displa-
ces the coordinated water molecule from the EuIII metal, ac-
companied by a pronounced increase in luminescence.
Addition of ATP (and ADP) to complex [Eu.3]+ also caused a
considerable increase in intensity of the hypersensitive DJ=4
band (675–705 nm), whereas AMP and HPO4
2 caused much
smaller changes (Figure S17 and S18). Moreover, the ATP and
ADP adducts of [Eu.3]+ could be discriminated by the variation
in spectral shape of the DJ=4 band; the ATP bound species is
characterized by two discernable lines centred at 688 and
697 nm, respectively, whereas the ADP adduct showed at least
4 components within the DJ=4 region. The structurally related
complex [Eu.4]+ showed similar distinctive changes in the
shape of the DJ=4 band in the presence of ATP and ADP;
however, only minor increases in emission intensity took place
(Figures S17 and S18).
Apparent binding constants were determined for complexes
[Eu.1–4]+ and a range of NPP anions by following the change
in the intensity ratio of the DJ=2/DJ=1 (605–630/580–
600 nm) emission bands as a function of anion concentration,
followed by a non-linear, least squares curve-fitting procedure
based on a 1:1 binding model (Table 2 and Figure S19–S49).1
[Eu.3]+ showed the strongest binding to ATP and ADP (logKa=
5.8 and 5.7 respectively), approximately 10 times stronger than
to AMP and pyrophosphate (PPi), and 100 times stronger than
to HPO4
2@ and HCO3
@ (logKa=2.7 and 3.0 respectively). [Eu.1]
+
showed a similar level of selectivity between ATP, ADP, AMP
and PPi, however the affinity for each anion was approximately
one order of magnitude lower, and HPO4
2@ was bound weakly
(logKa=2.1). The higher affinity of [Eu.3]
+ for ATP compared to
[Eu.1]+ can be attributed to replacement of the negatively
charged carboxylate donors in [Eu.1]+ with neutral carbonyl
amide donors in [Eu.3]+ , increasing the electropositive nature
of the EuIII ion, causing it to interact more strongly with ATP.
Figure 3. Change in emission spectra of [Eu.3]+ (5 mm) as a function of
added ATP (0–180 mm) in aqueous solution at pH 7.0; (Inset) Binding iso-
therm and fit to the experimental data, for logKa=5.8(:0.1). Conditions:
10 mm HEPES buffer, pH 7.0, lexc=330 nm, 25 8C.
Table 2. Apparent binding constants (logKa) determined for [Eu.1–4]
+
and different anionic species in aqueous solution (10 mm HEPES, pH 7.0,
25 8C).
Anion Log Ka
[a]
[Eu.1]+ [Eu.2]+ [Eu.3]+ [Eu.4]+
ATP 4.4 3.0 5.8 3.8
ADP 4.6 3.3 5.7 3.8
AMP 3.4 3.3 4.8 3.5
PPi 3.5 2.4 4.7 3.4
GTP 4.4 n/d 5.3 n/d
GDP 4.6 n/d 5.2 n/d
GMP 3.4 n/d 3.9 n/d
UTP 3.6 n/d 4.9 n/d
UDP 4.2 n/d 5.4 n/d
UMP 2.7 n/d 4.3 n/d
HPO4
2- 2.1 n/d 2.7 n/d
HCO3
- 3.0 n/d 3.0 n/d
[a] Each value represents the average of at least two duplicate titration
experiments. Errors in measurements were :0.1 with the statistical error
associated with the fit of the data <0.05. n/d=not determined.
1 Anion affinity constants for [Eu.3]+ were determined by plotting the change
in the ratio of the DJ=2/DJ=0 (605–630/575–582 nm) emission bands as a
function of anion concentration.
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The selectivity of [Eu.1]+ and [Eu.3]+ for ATP and ADP over
monophosphate anions can be attributed to increased Cou-
lombic attraction as well as stabilizing hydrogen bonding inter-
actions between the coordinated phosphate fragment of ATP
(and ADP) and the amide N-H groups of the quinoline chromo-
phores (Figure 1). In support of this, [Eu.2]+ and [Eu.4]+ ,
which lack amide groups, showed significantly lower affinities
and essentially no selectivity between ATP, ADP, AMP and PPi.
Hence, binding of NPP anions to [Eu.1]+ and [Eu.3]+ is not
governed solely by favourable electrostatic interactions, but in-
volves additional stabilization via hydrogen bonding that leads
to enhanced selectivity towards ATP and ADP over monophos-
phate species.
Complexes [Eu.1]+ and [Eu.3]+ were found to bind to the
guanosine and uridine phosphate anions with a similar level of
selectivity to that determined for the adenosine phosphate
series ; the general order of affinity was found to be NTP&
NDP>NMP. The nucleoside moiety appears to contribute to-
wards anion binding, as both [Eu.1]+ and [Eu.3]+ bind to NMP
anions but show relatively weak affinity to HPO4
2@ (logKa=2.1
and 2.7 respectively), and bind to nucleoside diphosphate
anions 10 times more strongly than to pyrophosphate. Due to
the lack of binding selectivity and small spectral responses ex-
hibited for [Eu.2]+ and [Eu.4]+ with adenosine phosphate
anions, affinity constants for other NPP anions were not deter-
mined.
Data in support of 1:1 binding between [Eu.3]+ and ATP or
GTP was provided by high resolution (ESI) mass spectrometry,
which gave intense signals at m/z=741.6588 and 749.6564,
corresponding to the doubly charged species [Eu.3+ATP+
5H]2+ and [Eu.3+GTP+5H]2+ respectively (Figure S50 and
S51).2 Mass spectral data showing the formation of stable ter-
nary adducts of [Eu.1]+ and ATP or ADP was reported previ-
ously.[31]
Effect of Mg2+ ions in solution
The majority of intracellular ATP exists in the form Mg-ATP2@.[34]
Therefore, a cellular imaging probe for ATP should ideally be
able to bind to the Mg-ATP2@ complex. Indeed, enzymes that
require ATP as a substrate, such as ATPases and kinases, utilize
Mg2+ ions to provide additional stabilization of the ATP-
enzyme complex.[35] The binding interaction between Mg2+
ions and ATP in water at physiological pH is approximately 50
times stronger than the interaction with ADP, with logKa (Mg-
ATP)=4.2 and logKa (Mg-ADP)=3.6.
[36] The presence of Mg2+
ions in aqueous solution was expected to influence the ability
of complexes [Eu.1]+ and [Eu.3]+ to discriminate between ATP
and ADP. Indeed, previously reported synthetic receptors have
shown limited discrimination between ATP and ADP at enzyme
relevant concentrations of Mg2+ ions.[26,37] We showed recently
that [Eu.1]+ can discriminate effectively between ATP and ADP
in a buffered aqueous solution containing 3 mm Mg2+ ions:
adding 1 mm ADP caused an 8-fold increase in overall EuIII
emission intensity compared to a much smaller 2.5-fold inten-
sity increase in the presence of 1 mm ATP.[24] Excellent discrimi-
nation between ATP and ADP was attributed to the slightly
higher affinity of [Eu.1]+ for ADP (Table 1) as well as the higher
competition between Mg2+ and ATP compared to ADP. This al-
lowed the change in the ratio of ATP/ADP to be dynamically
followed during the course of a kinase-catalyzed phosphoryla-
tion reaction.
Complex [Eu.3]+ showed a different discriminatory behav-
iour between ATP and ADP in the presence of Mg2+ ions. Fig-
ure 4A shows the emission spectral response of [Eu.3]+ in the
presence of 2 mm ATP, ADP, AMP and HPO4
2@ in a fixed back-
ground of 5 mm Mg2+ ions. Adding 2 mm ATP resulted in a
substantial 24-fold enhancement in intensity of the DJ=2
emission band, whereas ADP caused a smaller 13-fold increase
in luminescence. Only minor changes in emission spectra took
place in the presence of AMP and HPO4
2@. Titrations of ADP
and AMP into an aqueous solution containing [Eu.3]+ and
5 mm Mg2+ ions resulted in standard hyperbolic curves that
were fitted to a 1:1 binding model (Figure S56 and S57). Ap-
parent association constants were determined to be logKa=4.6
and 3.8 for ADP and AMP respectively, approximately 1 order
of magnitude lower than those determined in the absence of
MgCl2 (Table 2).
A titration of ATP in a fixed background of 5 mm Mg2+ ions
generated an isotherm consistent with the occurrence of two
distinct emissive species (Figure 4C). Incremental addition of
Figure 4. Selective spectral response of [Eu.3]+ for ATP in the presence of Mg2+ ions. (A) Change in emission spectra of [Eu.3]+ (5 mm) in the presence of
2 mm ATP, ADP, AMP and HPO4
2@ in a fixed background of 5 mm MgCl2 ; (B) Variation in emission spectra of [Eu.3]
+ upon addition of ATP (0–3 mm) in a fixed
background of 5 mm MgCl2 ; (C) Increase in intensity of the DJ=2 band (605–630 nm) of [Eu.3]
+ as a function of ATP concentration. Conditions: 10 mm
HEPES buffer, pH 7.4, lexc=330 nm, 25 8C.
2 Major ESI mass spectral signals were also obtained for the ternary adducts of
[Eu.4]+ bound to 1 molecule of ATP or GTP (Figures S53 and S54).
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0–1.5 mm ATP gave rise to a 4-fold increase in emission intensi-
ty of the DJ=2 band, and subsequent addition of 1.5–3.0 mm
ATP induced a further 3-fold enhancement in EuIII emission,
with no discernable change in spectral form. This can be as-
cribed to the formation of two discrete ternary adducts, each
exhibiting a similar coordination environment at the EuIII ion. It
is hypothesized that [Eu.3]+ binds to either ATP or the Mg-
ATP2@ complex; with the binding geometry between [Eu.3]+
and Mg-ATP2@ being similar to that of ATP, and stabilization of
the negatively charged triphosphate fragment provided by the
Mg2+ ion (Figure 1B). During the ATP titration, the concentra-
tion of Mg-ATP2@ increases, leading to the formation of a
highly emissive ternary complex. High resolution mass spectro-
metric data supported binding of [Eu.3]+ to Mg-ATP2@, giving
an intense signal at 752.6439 corresponding to the doubly
charged species [Eu.3+ATP+Mg+3H]2+ , which was in excel-
lent agreement with the calculated isotopic distribution (Fig-
ure S52). A titration of ATP in a fixed background of NaCl
(100 mm) revealed a classic isotherm for a simple 1:1 binding
system, with an apparent binding constant of logKa=5.0 (Fig-
ure S58). This confirms that the changes in emission spectra of
[Eu.3]+ in the presence of Mg2+ ions cannot be simply a result
of the additional ionic strength of the medium, rather it is the
specific interactions between Mg2+ , ATP and the EuIII complex
that modulates the equilibrium speciation and resulting emis-
sion response.
Monitoring ATPase activity in real-time
Having established that [Eu.3]+ exhibits distinctive spectral re-
sponses towards ATP and ADP in a background of 5 mm Mg2+
ions (Figure 4A), we demonstrated the ability of the EuIII com-
plex to monitor the apyrase-catalyzed hydrolysis of ATP to ADP
in real-time. Apyrase is an enzyme that catalyzes the conver-
sion of ATP into ADP, releasing energy in the process. To a buf-
fered aqueous solution (10 mm HEPES, pH 7.0, 5 mm MgCl2)
containing [Eu.3]+ (5 mm) and ATP (2 mm) was added different
amounts of apyrase (80–160 mU, ATP/ADP selectivity ratio,
10:1). The conversion of ATP to ADP and HPO4
2@ caused a
time-dependent decrease in emission intensity of the DJ=2
band centred at 614 nm and a smaller increase in intensity at
594 nm within the DJ=1 band (Figure 5A). These changes in
spectral form are consistent with competitive displacement of
the bound ATP by ADP, as the concentration of ADP increases.
Plots of the emission intensity ratio at 614/594 nm as a func-
tion of time revealed that the rate of ATP hydrolysis was direct-
ly proportional to the amount of enzyme added (Figure 5B).
The background reaction in the absence of enzyme showed
essentially no change in emission intensity during the time
frame of the experiment. The ratiometric changes in emission
intensity observed during the enzyme reaction were in good
agreement with those obtained in a simulated ATPase reaction,
in which the ratio of ATP/ADP was varied systematically (Fig-
ure 5D).
Given that [Eu.3]+ binds strongly to ATP, the possibility that
the probe lowers the effective concentration of ATP must be
considered, as this would influence the rate of reaction.
Figure 5. Continuous monitoring of apyrase catalyzed hydrolysis of ATP. (A) Change in emission spectra of [Eu.3]+ (570–630 nm) during the apyrase (80 mU)
catalyzed hydrolysis of ATP to ADP; (B) Time-trace plots showing the decrease in emission intensity ratio at 614/954 nm in the presence of different amounts
of apyrase (0, 80 or 160 mU); (C) Linear change in emission intensity of [Eu.3]+ during the initial stages of the enzyme reaction; (D) Plot of the emission inten-
sity ratio at 614/594 nm versus mole fraction of ADP, in the absence of apyrase (total nucleotide, [ATP]+ [ADP], is constant at 2 mm). Conditions: 10 mm
HEPES, pH 7.0, [Eu.3]+ (5 mm), apyrase (80 or 160 mU), ATP (2 mm), MgCl2 (5 mm). lexc=330 nm, 25 8C.
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However, anion binding to [Eu.3]+ is fast and reversible, and
due to the highly sensitive nature of the luminescence re-
sponse, the amount of [Eu.3]+ required to monitor the ATPase
assay is much lower (5 mm) compared to the concentration of
ATP (2 mm). This ensures that the rate of ATP hydrolysis is not
perturbed by the presence of [Eu.3]+ .
Figure 5C shows the linear decrease in emission intensity
ratio at 614/594 nm during the initial stages (0–9 minutes) of
each enzyme reaction. Reducing the amount of enzyme from
160 mU to 80 mU resulted in a decrease in the initial rate of
ATP hydrolysis by a factor of two. Thus, [Eu.3]+ is able to di-
rectly and continuously monitor ATPase activity by providing
an instantaneous and ratiometric luminescent signal, without
the need to chemically modify the enzyme or its substrate.[38]
Evaluating affinity to proteins
Encouraged by the ability [Eu.3]+ to monitor the enzymatic
conversion of ATP to ADP in real-time, we wished to evaluate
the ability of [Eu.3]+ to monitor fluctuations in ATP levels in
living mammalian cells. A cellular imaging probe for ATP must
be able to operate in the presence of proteins. Emissive metal
coordination complexes are known to interact non-covalently
with proteins, often causing quenching or enhancement of
emission.[39] We measured the affinity of complexes [Eu.1]+
and [Eu.3]+ for human serum albumin (HSA), the most abun-
dant protein in human blood plasma. Addition of HSA (0-
0.4 mm) to [Eu.1]+ at pH 7.0 resulted in a 3.5 fold increase in
overall EuIII emission intensity and distinctive changes in spec-
tral form (Figure 6A). A plot of the intensity ratio of the DJ=2/
DJ=1 emission bands versus HSA concentration allowed an
estimation of the association constant, logKa=4.8 (Kd=16 mm)
(Figure S59). Luminescence lifetimes for the protein bound
species in H2O and D2O were found to be 0.92 and 1.73 ms, re-
spectively, corresponding to a hydration state, q=0. Thus,
binding of [Eu.1]+ to HSA involves displacement of the bound
water molecule, possibly by coordination of an aspartate or
glutamate residue of HSA.
In sharp contrast, incremental addition of HSA to [Eu.3]+
caused a minor (10%) increase in EuIII emission intensity and
no change in spectral form (Figure S60). Analysis of the lumi-
nescence lifetimes of [Eu.3]+ in the presence of HSA in H2O
and D2O suggested displacement of the bound water mole-
cule. A lower apparent binding affinity was estimated between
[Eu.3]+ and HSA (logKa=3.2), which is approximately 2.5
orders of magnitude lower than the binding constant deter-
mined for this complex and ATP, under the same conditions.
The minimal interaction observed between [Eu.3]+ and HSA
could be tentatively attributed to the presence of two ancillary
carboxylate groups in the macrocyclic ligand, which could min-
imize the occurrence of hydrophobic interactions between the
EuIII complex and the protein. Gratifyingly, addition of increas-
ing amounts of ATP (0-0.5 mm) to [Eu.3]+ in a fixed back-
ground of 0.4 mm HSA gave rise to a measurable 3-fold in-
crease in emission intensity of the DJ=2 band (Figure 6B),
consistent with competitive displacement of the bound pro-
tein from [Eu.3]+ , upon binding to ATP. The apparent binding
constant was estimated to be logKa=4.0 (Figure S61), around
two orders of magnitude lower than that determined between
[Eu.3]+ and ATP in the absence of protein. Conversely, [Eu.1]+
was unable to signal the presence of ATP under the same con-
ditions.
ATP recognition in simulated intracellular fluid
The above competition experiments, involving biologically rel-
evant amounts of protein and Mg2+ ions, encouraged us to ex-
amine the ability of [Eu.3]+ to detect ATP in an aqueous
medium that mimics the complex ionic environment within
cells. In a healthy cell, the most abundant NPP anion is ATP,
which is estimated to be present in concentrations between
1–5 mm (average 2.5 mm).[1,12] The majority of ATP is generated
by the mitochondria by oxidative phosphorylation. Importantly,
ADP is maintained at a significantly lower concentration (50–
200 mm), the majority of which is bound strongly to protein,
such that the ATP/ADP ratio ranges between 5 and 100.[40] This
ATP/ADP ratio acts as a critical modulator of a variety of cellu-
lar events. Other NPP anions including GTP, UTP and CTP are
estimated to be present in concentrations 5-fold lower than
that of ATP. An intracellular probe must be able to respond se-
lectively to ATP under these conditions.
Using the above concentrations of NPP anions, we prepared
a simulated intracellular fluid based on a modified Krebs saline
solution, which is commonly used in cell and tissue culture
Figure 6. Differential responses of [Eu.1]+ and [Eu.3]+ to human serum albumin. (A) Change in emission spectra of [Eu.1]+ in the presence of increasing
amounts of HSA (0-0.4 mm) ; (B) Increase in emission spectra of [Eu.3]+ upon titration of ATP (0-0.5 mm) in a fixed background of 0.4 mm HSA. Conditions:
HEPES buffer (10 mm, pH 7.0), lexc=330 nm, 25 8C.
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experiments. The solution contains ADP (0.1 mm), GTP
(0.5 mm) and UTP (0.5 mm), NaH2PO4 (0.9 mm), PPi (0.05 mm),
KCl (110 mm), NaCl (10 mm), CaCl2 (2.5 mm), MgCl2 (8 mm),
Na2SO4 (0.5 mm), sodium lactate (2.3 mm), sodium citrate
(0.13 mm), glutathione (3 mm) and HSA (0.4 mm), buffered at
pH 7.4 using 10 mm HEPES. Under these conditions, incremen-
tal addition of 0–6 mm ATP to [Eu.3]+ (50 mm) resulted in a re-
producible 55% enhancement in emission intensity of the
DJ=2 band centred at 614 nm (Figure 7). Crucially, the in-
crease in EuIII emission intensity was approximately linear over
a biologically relevant ATP concentration range of 0.3 to
8.0 mm, corresponding to an increase in the ATP/ADP ratio
from 3 to 80 (Figure 7, inset). These competition experiments
strongly indicated that [Eu.3]+ could be used to signal
changes in the ATP/ADP ratio in cellulo, allowing a range of
biological processes to be followed in real-time.
Before undertaking cellular imaging studies, the pH depend-
ence of the emission response of [Eu.3]+ in the presence of
2 mm ATP was assessed. The emission intensity and spectral
form was essentially unchanged between pH 6.4 and 8.6 (Fig-
ure S62), suggesting that the luminescence signal should not
be affected by pH fluctuations around normal mitochondrial or
cytoplasmic pH, estimated to be near 7.3 and 8.0, respective-
ly.[34] This is significant, as previously reported ATP-selective
imaging probes have been shown to be sensitive to changes
in intracellular pH.[6, 7c] Additionally, certain existing methods
for measuring intracellular ATP are dependent on dissolved
oxygen concentration (e.g. the bioluminescent luciferase reac-
tion).[9] To confirm that [Eu.3]+ is not sensitive to changes in
dissolved oxygen, emission spectra were recorded for [Eu.3]+
alone, and in the presence of 2 mm ATP, in air-equilibrated and
degassed aqueous solution. The EuIII complex showed less
than 5% variation in emission intensity under these conditions
(Figure S63), with no significant change in emission intensity
being observed after bubbling of the air-equilibrated sample
with oxygen gas for 10 minutes.
Imaging mitochondrial ATP in living cells
Cellular uptake and localization studies
The cellular uptake behaviour of [Eu.3]+ was examined in NIH-
3T3 cells using fluorescence and laser scanning confocal mi-
croscopy (LSCM).[42] Incubation of [Eu.3]+ (50 mm) in NIH-3T3
cells for 2 hours resulted in uptake of the EuIII complex and
predominant localization to the mitochondria (lexc 355 nm, lem
605–720 nm), verified by co-localization studies using Mito-
Tracker Green (lexc 488 nm, lem 500–530 nm, Pearson’s correla-
tion coefficient, P=0.91) (Figure 8). The preferential distribu-
tion of [Eu.3]+ in the mitochondria could be tentatively attrib-
uted to the overall positive charge of the EuIII complex and the
amphipathic nature of the macrocyclic ligand.[16] Imaging was
possible over extended time periods (up to 8 hours), during
which time the brightness of the observed images did not
vary significantly (:10%) and the cells appeared to be healthy
and proliferating (see supporting information for detailed anal-
ysis of probe brightness within cells).
Cytotoxicity and vitality studies were undertaken for [Eu.3]+
at 24 hours using image cytometry assays, involving DAPI and
Acridine Orange stains, which revealed an IC50 value of greater
than 200 mm. Considering that the incubation concentration of
[Eu.3]+ is four times lower than this value, it can be assumed
that the EuIII complex is essentially non-toxic during the time
frame of the imaging experiments. Analysis of ICP-MS data
showed that for 4V106 NIH-3T3 cells incubated with [Eu.3]+
(50 mm) for 2 hours, a given cell contained 69 mm (:5%) of EuIII
metal, consistent with the accumulation of [Eu.3]+ within the
mitochondria during the incubation period.
Imaging elevated mitochondrial ATP levels
We evaluated the ability of [Eu.3]+ to visualize changes in the
concentration of ATP in NIH-3T3 cells upon treatment with
staurosporine, a broad-spectrum inhibitor of kinase activity
that eventually induces cell apoptosis. Figure 9A shows time-
lapsed images of cells stained with [Eu.3]+ (50 mm) before
(0 min) and after treatment with staurosporine (10 nm). The
images revealed a gradual increase in the observed emission
Figure 7. Detection of ATP in a simulated intracellular fluid. Change in emis-
sion spectra of [Eu.3]+ (50 mm) upon titration of ATP over the physiological
concentration range (0–8 mm) ; (Inset) Linear increase in EuIII emission inten-
sity at 614 nm as a function of added ATP. Conditions: HEPES buffer (10 mm,
pH 7.4), ADP (0.1 mm), GTP (0.5 mm), UTP (0.5 mm), Na4P2O7 (0.05 mm),
Na2HPO4 (0.9 mm), NaCl (10 mm), KCl (110 mm), CaCl2 (2.5 mm), MgCl2
(8 mm), Na2SO4 (0.5 mm), sodium lactate (2.3 mm), sodium citrate (0.13 mm),
glutathione (3 mm), HSA (0.4 mm). lexc=330 nm, 25 8C.
Figure 8. LSCM images showing mitochondrial localization of the EuIII com-
plex. (A) Localization of [Eu.3]+ (50 mm) in the mitochondria of NIH-3T3 cells
(lexc 355 nm, lem 605–720 nm); (B) MitoTracker Green (lexc 488 nm, lem 500–
530 nm); (C) RGB merged image verifying co-localization (P=0.91).
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intensity (lem 605–720 nm) in the mitochondria over a
90 minute period. At 60 minutes post-staurosporine treatment,
the EuIII emission intensity had increased by approximately
65%, after which time the observed signal reached a plateau
(Figure 9B). No obvious signs of cell apoptosis were evident
during the time scale of the experiment, and the EuIII complex
remained localized to the mitochondria. As a control, cells in-
cubated with [Eu.3]+ without the addition of staurosporine
were examined, revealing less than 10% variation in the EuIII
emission intensity over the same time period (Figure S64). ICP-
MS studies of cells incubated with [Eu.3]+ and staurosporine
for 2 hours revealed essentially no change in the concentration
of accumulated EuIII metal, compared to cells grown in the ab-
sence of the kinase inhibitor (Figure S65). Therefore, treatment
with staurosporine does not appear to perturb cellular uptake
or efflux of the EuIII complex from cells.
These imaging experiments indicate that the concentration
of ATP in the mitochondrial region gradually increased during
the preapoptotic period (150 min) following treatment with
staurosporine. This is in agreement with previous reports of
elevated ATP levels in the cytosol7 and mitochondria[5a] upon
incubation with staurosporine. The mitochondria remained
intact during this time, suggesting that mitochondrial function-
al integrity is important during the early stages of apoptosis.
This is consistent with the notion that apoptosis is an energy
requiring process; the concentration of mitochondrial ATP in-
creases to supply chemical energy for a variety of intracellular
processes, such as enzymatic hydrolysis of macromolecules.[7]
Monitoring depleted ATP levels in living cells
Next, the change in mitochondrial ATP levels was monitored
after treatment of cells with potassium cyanide, an inhibitor of
oxidative phosphorylation.[6a] Initially, NIH-3T3 cells were incu-
bated with [Eu.3]+ in a glucose-free growth medium, in order
to inhibit ATP production via glycolysis. Under these condi-
tions, a 20% decrease in emission intensity was observed after
2 hours compared to cells grown in the presence of glucose
(Figure S66). Subsequent addition of potassium cyanide
(0.1 mm) resulted in a significant and rapid decrease in the ob-
served emission intensity, with almost 85% of luminescence
lost after 10 minutes (Figure 10). These results suggest that mi-
Figure 9. Real-time monitoring of elevated levels of ATP in mitochondria. (A)
Time-lapsed LSCM images of NIH-3T3 cells stained with [Eu.3]+ (50 mm, lexc
355 nm, lem 605–720 nm) before (0 min) and after treatment with stauro-
sporine (10 nm), a potent inhibitor of protein kinases; (B) Time-dependent
increase in emission intensity (605–720 nm) of cells stained with [Eu.3]+ fol-
lowing treatment with staurosporine (10 nm).
Figure 10. Real-time monitoring of depleted mitochondrial ATP levels.
(A) Time-lapsed LSCM images of NIH-3T3 cells stained with [Eu.3]+ (50 mm,
lexc 355 nm, lem 605–720 nm) under glucose starvation conditions, before
(0 min) and after treatment with KCN (0.1 mm), an inhibitor of oxidative
phosphorylation; (B) Time dependent decrease in emission intensity of cells
stained with [Eu.3]+ following treatment with KCN (0.1 mm).
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tochondrial ATP is depleted substantially in the presence of
KCN, due to inhibition of oxidative phosphorylation, which is
consistent with previous studies that show a reduction in intra-
cellular ATP under similar conditions.[6a] ICP-MS analysis of cells
incubated with [Eu.3]+ for 30 minutes with KCN under glucose
starvation conditions showed less than 10% variation in the
concentration of accumulated EuIII metal, relative to untreated
cells grown in the presence of glucose. Therefore, the possibili-
ty that incubation with KCN promotes efflux of [Eu.3]+ from
the cells can be ruled out.
The inhibition of oxidative phosphorylation may result in
perturbation of mitochondrial bicarbonate concentration, as bi-
carbonate stimulates the enzymatic production of cyclic AMP,
which in turn activates mitochondrial kinase activity, regulating
ATP production.[43] Having already shown that the binding of
bicarbonate to [Eu.3]+ is approximately 100 times weaker than
that of ATP in buffered aqueous solution (Table 2), we wished
to investigate further the effect of varying intracellular bicar-
bonate concentration on the emission intensity of [Eu.3]+ . Fol-
lowing a procedure described previously,[19a] NIH-3T3 cells were
loaded with [Eu.3]+ (50 mm) and the percentage of atmospher-
ic CO2 in the cell imaging chamber was varied between 2%
and 7% CO2. The Eu
III emission intensity observed in the mito-
chondria of NIH-3T3 cells after an incubation period of 60 mi-
nutes was compared to those obtained when the incubation
was performed at a constant atmospheric CO2 of 5% for the
same time period. The LCMS images revealed less than 5%
modulation of emission intensity upon variation of the atmos-
pheric CO2 (Figure S67). These microscopy experiments indi-
cate that [Eu.3]+ does not respond significantly to fluctuations
in the equilibrium cellular bicarbonate concentration, which is
expected considering the lower apparent binding constant of
[Eu.3]+ to bicarbonate, and the larger emission intensity of the
ATP-bound EuIII complex.
Taken together, these live-cell imaging experiments demon-
strate that [Eu.3]+ is capable of signalling changes in the con-
centration of ATP in the mitochondria upon incubation with an
ATP synthesis inhibiter (KCN) and a kinase activity inhibitor
(staurosporine), and could provide a versatile imaging tool for
studying cell metabolism and other ATP-requiring processes in
real-time, within a targeted organelle.
Conclusions
We have developed a discrete, cationic EuIII complex for moni-
toring dynamic changes in the concentration of ATP within the
mitochondria of living cells. A series of luminescent EuIII com-
plexes, [Eu.1–4]+ , was synthesised that bind reversibly to nu-
cleoside polyphosphate anions with differential affinities in
buffered aqueous solution at physiological pH. The affinity of
the EuIII complexes towards NPPs and the magnitude of the
emission spectral response is tunable by making modifications
to the ligand structure. Hydrogen bond donor groups were in-
troduced into the quinoline units of [Eu.1]+ and [Eu.3]+ to en-
hance selectivity towards ATP and ADP over monophosphate
anions. Complex [Eu.3]+ , bearing two neutral carbonyl amide
donors, binds most strongly to ATP (logKa=5.8), forming a
stable ternary complex that exhibits intense, long-lived EuIII lu-
minescence. [Eu.3]+ can discriminate effectively between ATP,
ADP and AMP in a competitive aqueous medium that simu-
lates the complex ionic environment present in cells. The
probe provides a linear, ratiometric emission response that is
proportional to the ratio of ATP/ADP, enabling the enzymatic
hydrolysis of ATP to ADP to be precisely monitored in real-
time.
Cellular localization studies revealed that [Eu.3]+ preferen-
tially stains the mitochondria of mammalian cells, and is re-
tained within this organelle over extended time periods. We
have shown that [Eu.3]+ can detect an increase in mitochon-
drial ATP concentration following treatment of cells with the
kinase inhibitor staurosporine. Additionally, [Eu.3]+ was able to
visualize a rapid decrease in mitochondrial ATP following treat-
ment with KCN, an inhibitor of oxidative phosphorylation.
Complex [Eu.3]+ offers a several advances in performance
compared to existing ATP-responsive probes, including a lumi-
nescence signal that is: 1) sensitive to ATP within the biologi-
cally relevant concentration range (1–5 mm) ; 2) minimally per-
turbed by changes in pH, dissolved oxygen or the presence of
protein; and 3) sufficiently long-lived to avoid interference
from UV-induced autofluorescence arising from biomolecules.
Such probes offer a new versatile tool for studying metabolism
and a range of biological processes involving ATP, with subcel-
lular resolution. The strategy employed here will be explored
further to design EuIII probes capable of monitoring spatio-
temporal ATP dynamics within different cellular compartments,
providing a ratiometric change in emission intensity that is in-
trinsically normalized.
Experimental Section
Comprehensive experimental details are provided in the support-
ing information, including: details of compound characterization,
UV/Vis and emission spectral data for [Eu.1–4]+ , luminescence ti-
tration experiments involving [Eu.1–4]+ and NPP anions (conduct-
ed in buffered aqueous solution and competitive aqueous media),
pH dependence of the emission profile of [Eu.3]+ , ICP-MS data,
cellular imaging analysis and selected LSCM images of [Eu.3]+ in
NIH-3T3 cells.
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